Topics from this paper
13 Citations
Anastrozole as aromatase inhibitor – new approaches to breast cancer treatment in postmenopausal women
- Medicine
- 2019
- PDF
Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer
- Chemistry, Medicine
- Drug Delivery and Translational Research
- 2018
- 14
Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells
- Medicine
- Saudi medical journal
- 2017
- 6
- PDF
FUNGAL KAYNAKLI BASSİATİN’İN (3R,6R) MEME KANSERİ HÜCRE HATLARI ÜZERİNDEKİ ETKİSİNİN ARAŞTIRILMASI
- Art
- 2017
Cyclophosphamide and epirubicin-induced diabetes mellitus in breast cancer: A rare occurrence
- Medicine
- Journal of pharmacology & pharmacotherapeutics
- 2016
- 5
Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification
- Chemistry, Medicine
- Scientific reports
- 2016
- 32
- PDF
References
SHOWING 1-10 OF 32 REFERENCES
Effect of simvastatin on the pharmacokinetics of anastrozole.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2009
- 1
Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p450?
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2006
- 24
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
- Medicine
- The New England journal of medicine
- 2005
- 1,447
- PDF
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2005
- 991
Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol
- Chemistry, Medicine
- Clinical pharmacokinetics
- 2005
- 128
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial.
- Medicine
- The Lancet. Oncology
- 2005
- 193
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2005
- 437
- PDF
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.
- Medicine
- The New England journal of medicine
- 2004
- 1,722
- PDF
Arimidex®: A potent and selective fourth-generation aromatase inhibitor
- Biology, Medicine
- Breast Cancer Research and Treatment
- 2004
- 150